We then used transwell assays of CD8 T cells with AML-activated BM ST2+ Treg cells and showed that AML-activated BM ST2+ Treg cells are able to kill BM leukemic CD8 T cells in a contact-dependent manner (no killing in transwell assays; Fig. 8B). This evidence concerns the gene IL1RL1 and acute myeloid leukemia.